| Age (years) . | Patient No. (% of total) . |
|---|---|
| under 20 | 3 (10) |
| 20–29 | 11 (33) |
| 30–39 | 10 (30) |
| 40–49 | 5 (15) |
| 50–59 | 2 (6) |
| over 60 | 2 (6) |
| Sex | |
| Male | 13 (39) |
| Female | 20 (63) |
| Race | |
| White | 19 (58) |
| Black or African | 13 (39) |
| Other/unknown | 1 (3) |
| Non-Crohn’s Subjects | 8 |
| CD SubjectsMontreal Phenotype | |
| B1-nonstricturing, non penetrating | 7 |
| B2-stricturing | 9 |
| L1-ileal | 6 (67%) |
| L3-ileo-colic | 3 (33%) |
| B3-Penetrating | 9 |
| Age (years) . | Patient No. (% of total) . |
|---|---|
| under 20 | 3 (10) |
| 20–29 | 11 (33) |
| 30–39 | 10 (30) |
| 40–49 | 5 (15) |
| 50–59 | 2 (6) |
| over 60 | 2 (6) |
| Sex | |
| Male | 13 (39) |
| Female | 20 (63) |
| Race | |
| White | 19 (58) |
| Black or African | 13 (39) |
| Other/unknown | 1 (3) |
| Non-Crohn’s Subjects | 8 |
| CD SubjectsMontreal Phenotype | |
| B1-nonstricturing, non penetrating | 7 |
| B2-stricturing | 9 |
| L1-ileal | 6 (67%) |
| L3-ileo-colic | 3 (33%) |
| B3-Penetrating | 9 |
| Age (years) . | Patient No. (% of total) . |
|---|---|
| under 20 | 3 (10) |
| 20–29 | 11 (33) |
| 30–39 | 10 (30) |
| 40–49 | 5 (15) |
| 50–59 | 2 (6) |
| over 60 | 2 (6) |
| Sex | |
| Male | 13 (39) |
| Female | 20 (63) |
| Race | |
| White | 19 (58) |
| Black or African | 13 (39) |
| Other/unknown | 1 (3) |
| Non-Crohn’s Subjects | 8 |
| CD SubjectsMontreal Phenotype | |
| B1-nonstricturing, non penetrating | 7 |
| B2-stricturing | 9 |
| L1-ileal | 6 (67%) |
| L3-ileo-colic | 3 (33%) |
| B3-Penetrating | 9 |
| Age (years) . | Patient No. (% of total) . |
|---|---|
| under 20 | 3 (10) |
| 20–29 | 11 (33) |
| 30–39 | 10 (30) |
| 40–49 | 5 (15) |
| 50–59 | 2 (6) |
| over 60 | 2 (6) |
| Sex | |
| Male | 13 (39) |
| Female | 20 (63) |
| Race | |
| White | 19 (58) |
| Black or African | 13 (39) |
| Other/unknown | 1 (3) |
| Non-Crohn’s Subjects | 8 |
| CD SubjectsMontreal Phenotype | |
| B1-nonstricturing, non penetrating | 7 |
| B2-stricturing | 9 |
| L1-ileal | 6 (67%) |
| L3-ileo-colic | 3 (33%) |
| B3-Penetrating | 9 |
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.
